EUVIMEDOpdag EUVIMED
Multizentrische StudieBeobachtungsstudie

Long‐Term Dynamic Changes of Alanine Aminotransferase Levels Are Associated With Liver‐Related Events in Nucleos(t)ide Analogue‐Treated Chronic Hepatitis B Patients in China

Rong Fan iD, Ning Yu, Jimmy Che-To Lai iD, Vicki Wing-Ki Hui, Jie Peng iD, Yongpeng Chen, Zhihong Liu iD, Xieer Liang, Henry Lik-Yuen Chan iD, Junhua Yin, Vincent Wai-Sun Wong iD, Chunxiu Zhong and 4 more

Alimentary Pharmacology & Therapeutics · 2025

DOI: 10.1111/apt.70195 ↗

At a glance

Multizentrische Studie in Alimentary Pharmacology & Therapeutics, 2025. Written by Rong Fan and 15 co-authors. Institution: Department of Infectious Diseases, Nanfang Hospital, Southern Medical University; State Key Laboratory of Organ Failure Research; Key Laboratory of I…. Major MEDLINE topics: Alanine Transaminase, Antiviral Agents, Hepatitis B, Chronic, Nucleosides. Cited 4 times so far (Crossref); 26 references. Funded by: National Key Research and Development Program of China, National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The role of alanine aminotransferase (ALT) dynamics during nucleos(t)ide analogue (NA) therapy in chronic hepatitis B (CHB) is unclear. We aimed to evaluate the correlation between ALT dynamics and liver‐related events (LRE), and explore the optimal threshold of ALT during NA treatment.

Methods

We enrolled 18,129 NA‐treated patients, comprising 3104 patients from the Search‐B study (NCT02167503) and 15,025 patients from a real‐world cohort in Hong Kong. Latent‐class mixed model (LCMM) was adopted to identify trajectory patterns of ALT during treatment. ALT value at the 95 th percentile of the trajectory group with the lowest LRE risk was obtained as the optimal threshold.

Results

During a median follow‐up of 53.3 months, 1164 patients developed LRE with a 7‐year cumulative incidence of 9.9%. In the Search‐B cohort, LCMM recognised 3 trajectory groups with progressively increasing ALT levels, which were positively associated with LRE risk. Subsequently, the optimal thresholds for ALT were obtained as 23 U/L for men and 16 U/L for women. The 7‐year cumulative incidence of LRE was 5.5% for ALT ≤ 23 or 16 U/L, significantly lower than that for ALT > 23 or 16 U/L but ≤ 40 U/L (10.8%; aHR = 2.0, p < 0.001), and ALT > 40 U/L (15.1%; aHR = 3.4, p < 0.001). Similarly, in the Hong Kong cohort, ALT > 23 or 16 U/L but < 40 U/L and ALT > 40 U/L also increased the LRE risk, with aHRs of 2.0 ( p = 0.003) and 6.1 ( p < 0.001), respectively.

Conclusion

On‐treatment ALT levels were significantly correlated with the prognosis of CHB. ALT ≤ 23 U/L for men and ≤ 16 U/L for women were identified as the optimal thresholds during NA treatment, suggesting that CHB patients should strive for a lower ALT level beyond the traditional normal range.

Subjects

MeSH terms (MEDLINE)

Alanine TransaminaseAntiviral AgentsHepatitis B, ChronicNucleosidesAdultFemaleHumansMaleMiddle AgedChinaFollow-Up StudiesHong Kong

Author keywords

alanine aminotransferasechronic hepatitis Blatent‐class mixed modelliver‐related events

Substances

Alanine TransaminaseAntiviral AgentsNucleosides

Authors and institutions

  • Department of Infectious Diseases, Nanfang Hospital, Southern Medical University; State Key Laboratory of Organ Failure Research; Key Laboratory of Infectious Diseases Research in South China, Ministry of Education; Gua…
  • Medical Data Analytics Centre, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Sciences, the Chinese University of Hong Kong, Hong Kong, SAR, China.

ORCID profiles: Rong Fan, Jimmy Che-To Lai, Jie Peng, Zhihong Liu, Henry Lik-Yuen Chan, Vincent Wai-Sun Wong, Jian Sun, Terry Cheuk-Fung Yip, Jinlin Hou

Funding

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province

Cite

APA

Fan, R., Yu, N., Lai, J. C., Hui, V. W., Peng, J., Chen, Y., Liu, Z., Liang, X., Chan, H. L., Yin, J., Wong, V. W., Zhong, C., Wong, G. L., Sun, J., Yip, T. C., & Hou, J. (2025). Long‐Term Dynamic Changes of Alanine Aminotransferase Levels Are Associated With Liver‐Related Events in Nucleos(t)ide Analogue‐Treated Chronic Hepatitis B Patients in China. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.70195

Vancouver

Fan R, Yu N, Lai JC, Hui VW, Peng J, Chen Y, et al. Long‐Term Dynamic Changes of Alanine Aminotransferase Levels Are Associated With Liver‐Related Events in Nucleos(t)ide Analogue‐Treated Chronic Hepatitis B Patients in China. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.70195

BibTeX
@article{Fan2025,
  author = {Fan, Rong and Yu, Ning and Lai, Jimmy Che-To and Hui, Vicki Wing-Ki and Peng, Jie and Chen, Yongpeng and Liu, Zhihong and Liang, Xieer and Chan, Henry Lik-Yuen and Yin, Junhua and Wong, Vincent Wai-Sun and Zhong, Chunxiu and Wong, Grace Lai-Hung and Sun, Jian and Yip, Terry Cheuk-Fung and Hou, Jinlin},
  title = {Long‐Term Dynamic Changes of Alanine Aminotransferase Levels Are Associated With Liver‐Related Events in Nucleos(t)ide Analogue‐Treated Chronic Hepatitis B Patients in China},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1111/apt.70195}
}
Start for free →